-
Mashup Score: 0
Navigating difficult conversations with patients facing advanced-stage cancer is an important part of shared decision making and ensuring patients feel engaged with their treatment plan.
Source: www.ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Patient Adherence to Oral Targeted Therapies — [VODCAST] Ep 18 - 3 year(s) ago
With the emergence of oral cancer therapies, it is a very exciting time in cancer care. But these treatments can come with adverse events.
Source: www.ascopost.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @ACCCBuzz: @maryam_lustberg @yalecancer @yalemed & Sandra Cuellar @UICPharm join the CANCER BUZZ vodcast: https://t.co/oJqEvdF0Ai Tune i…
-
-
Mashup Score: 0Clinical Research Award - 3 year(s) ago
The Clinical Research Award recognizes individuals whose research has significantly and positively impacted the oncology patient, family, and/or community. 2022 Clinical Research Award Recipient: Carmen Guerra, MD, MSCE, FACP Dr. Carmen Guerra is the Ruth C. and Raymond G. Perelman Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania. Dr. Guerra is a…
Source: www.ascopost.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Congratulations, Dr. Carmen Guerra!! Well-deserved! Clinical Research Award https://t.co/0Q70TW05Lw @PennCancer @UofPenn
-
-
Mashup Score: 2Annual Achievement Award - 3 year(s) ago
The Annual Achievement Award has been given since 1980 to distinguished individuals or organizations in a wide variety of fields, who have reflected values of community cancer care through their outstanding contributions. 2022 Annual Achievement Award Recipient: Lola A. Fashoyin-Aje, MD, MPH Lola A. Fashoyin-Aje, MD, MPH, is a medical oncologist and Deputy Director in the Division of…
Source: www.ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
OCE's @LolaFashoyinAje received the 2022 Association of Community Cancer Centers Annual Achievement Award, recognizing her efforts leading scientific and policy initiatives to address disparities in oncology drug development. @ACCCBuzz #OCEProjectEquity https://t.co/aAxhTmccFr https://t.co/DITEziT0eN
-
-
Mashup Score: 0Annual Achievement Award - 3 year(s) ago
The Annual Achievement Award has been given since 1980 to distinguished individuals or organizations in a wide variety of fields, who have reflected values of community cancer care through their outstanding contributions. 2022 Annual Achievement Award Recipient: Lola A. Fashoyin-Aje, MD, MPH Lola A. Fashoyin-Aje, MD, MPH, is a medical oncologist and Deputy Director in the Division of…
Source: www.ascopost.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Congratulations @LolaFashoyinAje. Impressive as always! Annual Achievement Award https://t.co/M26T0FYdha
-
-
Mashup Score: 2NOLA + Pathways Partnership: Meeting Patients’ Needs Locally - 3 year(s) ago
The final post in the NOLA series, ACCCBuzz shares how one independent oncology practice and local community center are taking action to improve equitable cancer care delivery at the local level.
Source: www.ascopost.comCategories: Hem/Oncs, Latest HeadlinesTweet-
NOLA + Pathways Partnership: Meeting Patients’ Needs Locally https://t.co/gCgdKblP5Q
-
-
Mashup Score: 1NOLA + Pathways Partnership: Meeting Patients’ Needs Locally - 3 year(s) ago
The final post in the NOLA series, ACCCBuzz shares how one independent oncology practice and local community center are taking action to improve equitable cancer care delivery at the local level.
Source: www.ascopost.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @ACCCBuzz: @OBRtweets @KashyappatelMd Learn more about @KashyappatelMd's many contributions: https://t.co/dAGewp0y0j
-
-
Mashup Score: 0Umbraco - www.ascopost.com - 4 year(s) ago
Password Show password Hide password
Source: www.ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
.@US_FDA Approves Daratumumab and Hyaluronidase-fihj With Pomalidomide and Dexamethasone for Pretreated Patients With Multiple Myeloma https://t.co/y8l2Ahhtne #mmsm #hematology
-
-
Mashup Score: 0
By Chase Doyle Posted: 3/15/2021 12:57:00 PM Last Updated: 3/15/2021 4:10:49 PM With three new HER2-targeted therapies approved in the past 15 months alone, the treatment landscape for patients with metastatic breast cancer has become increasingly crowded. In the third-line…
Source: www.ascopost.comCategories: Hem/Oncs, Latest HeadlinesTweet-
I for my part appreciate this embarrassment of riches: "Novel HER2-Targeted Therapies Pose Sequencing Challenges" #bcsm https://t.co/ttKjU5ky83
-
-
Mashup Score: 0Addition of Capivasertib to Docetaxel/Prednisolone in Patients With Metastatic Castration-Resistant Prostate Cancer - The ASCO Post - 5 year(s) ago
By Matthew Stenger Posted: 12/21/2020 10:00:00 AM Last Updated: 12/23/2020 2:56:44 PM In the phase II ProCAID study reported in the Journal of Clinical Oncology, Crabb et al found that the addition of the pan-AKT inhibitor capivasertib to docetaxel and prednisolone did not…
Source: www.ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Addition of Capivasertib to Docetaxel/Prednisolone in Patients With Metastatic Castration-Resistant Prostate Cancer https://t.co/D7DW68GQ2g #pcsm #oncology #cancer
-
Hear from Sunandana Chandra, MD, (@MunTheLoon) from @LurieCancer @NorthwesternMed about her approach to having difficult conversations with patients facing advanced #cancer. Listen to the @ACCCBuzz podcast: https://t.co/1qzq6bA1nd #palliativecare #SuppOnc #PallOnc https://t.co/nGnw5XbKd0